FELIPE ANDREIUOLO
Obtained his medical degree at UFF (Niterói) and completeR residency in Anatomic Pathology at INCa (Rio de Janeiro). Holds a Master Degree in Neuropathology (UFRJ, Rio de Janeiro). Lived for eleven years in Paris, France, where he obtained a PhD on molecular pathology of pediatric brain tumors (Université Paris XI) and worked as a fellow, then as a pathologist/ neuropathologist at Gustave Roussy and Hôpital Ste-Anne. Moved to Germany in 2016 pursuing his activities at the National Reference Center for the Diagnosis of Brain Tumors (Bonn). Since 2020 works as a neuropathologist at Instituto Estadual do Cérebro Paulo Niemeyer and Rede D’Or/IDOR (Rio de Janeiro).
Check the activity agenda
Friday, March 22, 2024
• Room 3
08:15-10:30
SESSION 1: PEDIATRIC POSTERIOR FOSSA TUMORS
Pediatric posterior fossa tumors: wich is the role of the radiologist?
Integrating IH up to methylation in the WHO Classification for diagnosis of posterior fossa tumors in children and adolescents.What does the neuro-oncologist need to know?
How to avoid complications in posterior fossa surgery for pediatric patients?
Safeness and complications of radiotherapy for pediatric posterior fossa patients
The Brazilian Medulloblastoma Protocol for children and adolescents > 4 years old
Unresectable Low-grade glioma: Chemotherapy x Target therapy, what is the best treatment at diagnosis?
Discussion
Moderator: Nasjla Saba da Silva (SP)
Moderator: Enrico Ghizoni (SP)
Pediatric posterior fossa tumors: wich is the role of the radiologist?
Speaker: Celso Hygino (RJ)
Integrating IH up to methylation in the WHO Classification for diagnosis of posterior fossa tumors in children and adolescents.What does the neuro-oncologist need to know?
Speaker: Felipe Andreiuolo (RJ)
How to avoid complications in posterior fossa surgery for pediatric patients?
Speaker: Jorge Bizzi (RS)
Safeness and complications of radiotherapy for pediatric posterior fossa patients
Speaker: Michael Jenwei Chen (SP)
The Brazilian Medulloblastoma Protocol for children and adolescents > 4 years old
Speaker: Sidnei Epelman (SP)
Unresectable Low-grade glioma: Chemotherapy x Target therapy, what is the best treatment at diagnosis?
Speaker: Jason Fangusaro (Estados Unidos)
Discussion
Monday, March 23, 2024
• Room 2
08:15-10:30
SESSION 3: SKULL BASE TUMORS
Update on the genetics of pituitary adenomas and a glimpse of the future
Multimodal non-surgical treatments of aggressive pituitary tumors
Advancements in pituary surgery for optimal outcomes
Surgical frontiers: advancements in treating craniopharyngiomas
Confronting recurrence: latest insights in treatment of craniopharyngiomas
Vestibular schwannomas: effectiveness and complications of SRS
Vestibular schwannomas: effectiveness and complications of mircosurgery
Discussion
Moderator: Mateus Reghin Neto (SP)
Moderator: Allan Dias Polverini (SP)
Moderator: Eduardo Weltman (SP)
Moderator: Mateus Dal Fabbro (SP)
Update on the genetics of pituitary adenomas and a glimpse of the future
Speaker: Felipe Andreiuolo (RJ)
Multimodal non-surgical treatments of aggressive pituitary tumors
Speaker: Andrea Glezer (SP)
Advancements in pituary surgery for optimal outcomes
Speaker: João Paulo Almeida (Estados Unidos)
Surgical frontiers: advancements in treating craniopharyngiomas
Speaker: João Paulo Almeida (Estados Unidos)
Confronting recurrence: latest insights in treatment of craniopharyngiomas
Speaker: Caroline Chaul (SP)
Vestibular schwannomas: effectiveness and complications of SRS
Speaker: Antonio de Salles (SP)
Vestibular schwannomas: effectiveness and complications of mircosurgery
Speaker: Ricardo Ramina (PR)
Discussion
Promoted by
Organization
Tourism agency
SILVER SPONSOR
BRONZE SPONSOR
SUPPORT SPONSOR
Institutional Support
